ARTICLE | Clinical News
Sativex sublingual cannabis extract spray regulatory update
September 6, 2010 7:00 AM UTC
Health Canada approved Sativex from GW Pharmaceuticals to treat spasticity due to multiple sclerosis (MS). The sublingual cannabis extract spray containing tetrahydrocannabinol (THC) and cannabidiol i...